Abstract:Abstract Introduction: Lung cancers demonstrate the highest number of p53 mutations of any cancer with 70% of small cell lung cancers and 33% of adenocarcinomas containing a mutation. Loss of p53 function has been correlated with therapeutic resistance and poor clinical outcomes. Therefore, developing therapeutic strategies that specifically target p53 loss-of-function mutants is of the utmost importance. The purpose of this investigation is to explore whether p53 status has impact on the radio-sensitizing effect of a DNA-PKcs inhibitor (NU7441). Methods: Clonogenic surviving fraction analysis, DNA double strand break repair kinetics, cell cycle analysis, immunofluorescence, immunoblot, apoptosis and autophagy assays were used to investigate the mechanism of radiosensitization of NU7441 in NSCLC cell lines (A549, H1299, and H460) with differential levels of p53 expression. Results: NU7441 substantially inhibited the repair of IR-induced DNA double strand break (DSB) in all three cell lines. Clonogenic surviving fraction analysis reveals that NU7441 is a better radio-sensitizer in p53-deficient cells (H1299) when compared to p53-wild type cells (A549, H460). Combination of ionizing radiation (IR) and NU7441 leads to a more robust G2 arrest in A549 and H460 cells when compared to radiation treatment only. However, NU7441 and radiation preferentially induced mitotic arrest in H1299 consequently leading to a significant increase in mitotic catastrophe. Furthermore, NU7441 led to an increase in apoptosis rather than autophagy as the predominant cell death pathway in p53-deficient cells. Moreover, knockdown of p53 using siRNA sensitized A549 to NU7441+IR treatment. Conclusion: Our study clearly shows that NU7441, a novel DNA-PKcs inhibitor, is a potent radio-sensitizer in p53-dificient lung cancer cells and highlights the promise of NU7441 in targeted cancer treatment. Citation Format: Yu Lan, Zengfu Shang, Feng-Ming Hsu, Vasu Tumati, Benjamin P. Chen, Debabrata Saha. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 4911. doi:10.1158/1538-7445.AM2014-4911

Inhibition of DNA-PKcs Enhances Radiosensitivity and Increases the Levels of ATM and ATR in NSCLC Cells Exposed to Carbon Ion Irradiation.

Inhibition of DNA‑PK Activity Sensitizes A549 Cells to X‑ray Irradiation by Inducing the ATM‑dependent DNA Damage Response

NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.

Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin

DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation Via Telomere Capping Disruption.

Abstract 4911: NSCLC Cells Demonstrate Differential Mode of Cell Death in Response to the Combined Treatment of Radiation and a DNA-PKcs Inhibitor

Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation

Sirt3 Promoted DNA Damage Repair and Radioresistance Through ATM-Chk2 in Non-small Cell Lung Cancer Cells

Association of Protein Kinase CK2 Inhibition with Cellular Radiosensitivity of Non-Small Cell Lung Cancer

Regulation of ATM in DNA Double Strand Break Repair Accounts for the Radiosensitivity in Human Cells Exposed to High Linear Energy Transfer Ionizing Radiation.

Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons

DNA-PKcs Inhibition Sensitizes Human Chondrosarcoma Cells to Carbon Ion Irradiation via Cell Cycle Arrest and Telomere Capping Disruption

Sirt3 Regulates Radioresistance of Non-small Cell Lung Cancer through ATM-Chk2 Pathway

Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status.

ATM Expression is Elevated in Established Radiation-Resistant Breast Cancer Cells and Improves DNA Repair Efficiency

Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death

Effect of an Inhibitor of Protein Kinase CK2 on Radiosensitivity of Human Lung Cancer Cells

Radiation Alters PD-L1/NKG2D Ligand Levels in Lung Cancer Cells and Leads to Immune Escape from NK Cell Cytotoxicity Via IL-6-MEK/Erk Signaling Pathway.

Remodeling of Chromatin Accessibility Regulates the Radiological Responses of NSCLC A549 Cells to High-LET Carbon Ions.

Blockage of PKM2 expression by gene silencing enhances the radiosensitivity of human lung cancer A549 cells

Radiation and chemo-sensitizing effects of DNA-PK inhibitors are proportional in tumors and normal tissues